BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24824077)

  • 1. Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Sato R; Kishiwada M; Kuriyama N; Azumi Y; Mizuno S; Usui M; Sakurai H; Tabata M; Yamada T; Isaji S
    J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):562-72. PubMed ID: 24824077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes after pancreaticoduodenectomy using pair-watch suturing technique: Different roles of pancreatic duct dilatation and remnant pancreatic volume for the development of pancreatic endocrine and exocrine dysfunction.
    Iizawa Y; Kato H; Kishiwada M; Hayasaki A; Tanemura A; Murata Y; Azumi Y; Kuriyama N; Mizuno S; Usui M; Sakurai H; Isaji S
    Pancreatology; 2017; 17(5):814-821. PubMed ID: 28705553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative Computed Tomography Assessments of the Pancreas Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy.
    Ohgi K; Okamura Y; Yamamoto Y; Ashida R; Ito T; Sugiura T; Aramaki T; Uesaka K
    Medicine (Baltimore); 2016 Feb; 95(6):e2535. PubMed ID: 26871772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency.
    Nakagawa N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Sasaki H; Okano K; Sueda T
    J Surg Oncol; 2014 Nov; 110(6):720-6. PubMed ID: 24965234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system.
    Kato H; Isaji S; Azumi Y; Kishiwada M; Hamada T; Mizuno S; Usui M; Sakurai H; Tabata M
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):296-304. PubMed ID: 19809782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of postoperative adjuvant chemotherapy on the development of nonalcoholic fatty liver disease after pancreatoduodenectomy.
    Nishikawa M; Aosasa S; Moriya T; Noro T; Hase K; Yamamoto J
    J Surg Res; 2016 Sep; 205(1):127-35. PubMed ID: 27621009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Yamamura K; Yamashita YI; Yamao T; Kitano Y; Arima K; Miyata T; Higashi T; Hayashi H; Beppu T; Baba H
    Ann Gastroenterol Surg; 2022 Jul; 6(4):555-561. PubMed ID: 35847431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated functional remnant pancreatic volume predicts nonalcoholic fatty liver disease after pancreaticoduodenectomy: use of computed tomography attenuation value of the pancreas.
    Maehira H; Iida H; Maekawa T; Yasukawa D; Mori H; Takebayashi K; Kaida S; Miyake T; Matsubara A; Tani M
    HPB (Oxford); 2021 May; 23(5):802-811. PubMed ID: 33046368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of predictive factors in patients with nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Ito Y; Kenmochi T; Shibutani S; Egawa T; Hayashi S; Nagashima A; Kitagawa Y
    Am Surg; 2014 May; 80(5):500-4. PubMed ID: 24887731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy.
    Okabe H; Yamashita YI; Inoue R; Kinoshita S; Itoyama R; Yusa T; Nakao Y; Yamao T; Umezaki N; Tsukamoto M; Kitano Y; Miyata T; Arima K; Hayashi H; Imai K; Chikamoto A; Baba H
    Surg Today; 2020 Feb; 50(2):193-199. PubMed ID: 31463596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Yamazaki S; Takayama T; Higaki T; Moriguchi M; Yoshida N; Miyazaki T; Teshima Y
    J Gastroenterol; 2016 Jan; 51(1):55-62. PubMed ID: 25904096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional remnant pancreatic volume ratio indicates postoperative pancreatic exocrine insufficiency in pancreatic cancer patients after distal pancreatectomy.
    Miyamoto R; Inagaki Y; Ikeda N; Oda T
    Pancreatology; 2020 Jul; 20(5):867-874. PubMed ID: 32654989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and morphological evolution of remnant pancreas after resection for pancreatic adenocarcinoma.
    Park SY; Park KM; Shin WY; Choe YM; Hur YS; Lee KY; Ahn SI
    Medicine (Baltimore); 2017 Jul; 96(28):e7495. PubMed ID: 28700497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
    Satoi S; Sho M; Yanagimoto H; Yamamoto T; Akahori T; Kinoshita S; Nagai M; Hirooka S; Yamaki S; Nishiwada S; Ryota H; Ikeda N; Nakajima Y; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Mar; 23(3):167-73. PubMed ID: 26748629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Nagai M; Sho M; Satoi S; Toyokawa H; Akahori T; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kinoshita S; Nishiwada S; Ikeda N; Kwon AH; Nakajima Y
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):186-92. PubMed ID: 23798362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy.
    Gaujoux S; Cortes A; Couvelard A; Noullet S; Clavel L; Rebours V; Lévy P; Sauvanet A; Ruszniewski P; Belghiti J
    Surgery; 2010 Jul; 148(1):15-23. PubMed ID: 20138325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy.
    Callery MP; Pratt WB; Kent TS; Chaikof EL; Vollmer CM
    J Am Coll Surg; 2013 Jan; 216(1):1-14. PubMed ID: 23122535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of obesity on surgical outcome after pancreaticoduodenectomy.
    Noun R; Riachy E; Ghorra C; Yazbeck T; Tohme C; Abboud B; Naderi S; Chalhoub V; Ayoub E; Yazbeck P
    JOP; 2008 Jul; 9(4):468-76. PubMed ID: 18648138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic encephalopathy following a Whipple operation].
    van Galen KP; Stam F; van Oijen AH
    Ned Tijdschr Geneeskd; 2009; 153():A463. PubMed ID: 19857276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative serum albumin correlates with postoperative pancreatic fistula after pancreaticoduodenectomy.
    Fujiwara Y; Shiba H; Shirai Y; Iwase R; Haruki K; Furukawa K; Futagawa Y; Misawa T; Yanaga K
    Anticancer Res; 2015 Jan; 35(1):499-503. PubMed ID: 25550594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.